Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Hofseth BioCare

Hofseth BioCare

1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK
1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK

Hofseth BioCare

Hofseth BioCare

1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK
1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK

Hofseth BioCare

Hofseth BioCare

1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK
1,295NOK
−5,82% (−0,080)
Päätöskurssi
Ylin1,450
Alin1,290
Vaihto
0,1 MNOK
2025 Q3 -tulosraportti

Vain PDF

36 päivää sitten

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
3 000
Myynti
Määrä
20 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
15--
9--
1 200--
1 320--
2 500--
Ylin
1,45
VWAP
-
Alin
1,29
VaihtoMäärä
0,1 99 853
VWAP
-
Ylin
1,45
Alin
1,29
VaihtoMäärä
0,1 99 853

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
13.2.2026
Menneet tapahtumat
2025 Q3 -tulosraportti7.11.
2025 Q2 -tulosraportti22.8.
2025 Q1 -tulosraportti16.5.
2024 Q4 -tulosraportti14.2.
2024 Q3 -tulosraportti8.11.2024
Datan lähde: FactSet, Quartr

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 8.12. · Muokattu
    ·
    8.12. · Muokattu
    ·
    When will the shares from the repair issue arrive in the ASK that were subscribed at a price of NOK 1.80?
    9.12.
    ·
    9.12.
    ·
    Interest in the repair issue was very low, which suggests that investors are starting to lose patience with the company, as promises of profit are constantly being postponed. This can have several consequences for both the company and the issue: 1. Low amount raised: If few shareholders subscribe, the company will not raise as much capital as planned. This could mean that the company does not get the funds it needs to finance projects, repay debt, or strengthen its balance sheet. 2. The issue may be postponed or canceled: Many issues have a «minimum threshold» for them to be carried out. If interest is low, the board may choose to postpone the issue, change the terms, or, in the worst case, cancel it. 3. Price pressure on the share: Low interest may indicate that the market does not value the company highly, which may mean that the issue price must be set lower to attract investors. This can lead to dilution for existing shareholders at a lower value than expected. 4. Signal to the market: Low interest can send a negative signal about the company's financial situation or future prospects. This can lead to a further fall in the share price, and make it more difficult to raise capital later. 5. The board may have to find alternative solutions: If the repair issue does not provide the desired capital, the company may have to consider other financing methods, such as loans, private placements, strategic partners, or cost cuts. In short: low interest in a repair issue is a bad sign for both the company's financial situation and shareholder values.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    This can also be an attractive opportunity for those who tolerate high risk, especially considering that founder Roger Hofseth himself has invested over 50 million kroner in the issuance. The risk is still significant, but I consider the downside risk to be limited, at least until 2026, from my perspective. The securities fund DNB SMB has completed a sell-off of over 2 million shares and is now completely out of the company.
  • 28.11.
    ·
    28.11.
    ·
    Is DNB momentarily empty?
  • 27.11.
    ·
    27.11.
    ·
    Smart to subscribe to rep.emi at kr. 1,8 😎
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    What is rep.emi?
  • 12.11.
    ·
    12.11.
    ·
    Rep emi was probably 1.8kr? A bit odd that it falls below
    13.11.
    ·
    13.11.
    ·
    A bit peculiar that they are experiencing a nearly 20 % decline in sales, while at the same time opening sales offices, entering into agreements, winning awards for their products, and hiring more people. Yes, there's a lot that seems a bit peculiar with this company.
  • 23.10.
    ·
    23.10.
    ·
    The stock will probably go up when the new factory is up and running. https://www.opp.no/naeringsliv/mn24/n/1M0Jbe/sikrer-fabrikkutbygging-med-utenlandsk-partner
    24.10.
    ·
    24.10.
    ·
    MN24 Secures major expansion with foreign giant company German giant company contributes with a large loan to Hofseth Biocare which secures the expansion of the factory at Berkåk – and a tripling of exports from the Rennebu company. Hofseth Biocare has operated in Tine's old dairy premises at Berkåk, and is now planning a major expansion. PHOTO: JAN INGE FLÅ Per Roar Bekken Editor Updated: February 21, 2025 at 13:38 The expansion was announced in December. Managing Director of Hofseth Biocare ASA, Jon Olav Ødegård, then indicated to OPP an investment of between 100 and 200 million and a fivefold increase in staff from 8 to 40 employees. READ ALSO: Announces giant expansion: – Provides over 30 new jobs On Friday, the listed company issued a stock exchange announcement that they have entered into a partnership with the German giant corporation Symrise AG. The group enters and finances the expansion through a loan of 5 million euro (58 million kr). The facility at Berkåk is now fully financed with Symrise's loan and 60 million kroner in loans from Sparebank1 Nordmøre. "We expect all permits for the expansion of the facility to be approved by the second quarter of 2025, and the construction of the new hydrolysis plant will start immediately thereafter. Preliminary production start is set for the second quarter of 2027.", it states in the announcement.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti

Vain PDF

36 päivää sitten

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 8.12. · Muokattu
    ·
    8.12. · Muokattu
    ·
    When will the shares from the repair issue arrive in the ASK that were subscribed at a price of NOK 1.80?
    9.12.
    ·
    9.12.
    ·
    Interest in the repair issue was very low, which suggests that investors are starting to lose patience with the company, as promises of profit are constantly being postponed. This can have several consequences for both the company and the issue: 1. Low amount raised: If few shareholders subscribe, the company will not raise as much capital as planned. This could mean that the company does not get the funds it needs to finance projects, repay debt, or strengthen its balance sheet. 2. The issue may be postponed or canceled: Many issues have a «minimum threshold» for them to be carried out. If interest is low, the board may choose to postpone the issue, change the terms, or, in the worst case, cancel it. 3. Price pressure on the share: Low interest may indicate that the market does not value the company highly, which may mean that the issue price must be set lower to attract investors. This can lead to dilution for existing shareholders at a lower value than expected. 4. Signal to the market: Low interest can send a negative signal about the company's financial situation or future prospects. This can lead to a further fall in the share price, and make it more difficult to raise capital later. 5. The board may have to find alternative solutions: If the repair issue does not provide the desired capital, the company may have to consider other financing methods, such as loans, private placements, strategic partners, or cost cuts. In short: low interest in a repair issue is a bad sign for both the company's financial situation and shareholder values.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    This can also be an attractive opportunity for those who tolerate high risk, especially considering that founder Roger Hofseth himself has invested over 50 million kroner in the issuance. The risk is still significant, but I consider the downside risk to be limited, at least until 2026, from my perspective. The securities fund DNB SMB has completed a sell-off of over 2 million shares and is now completely out of the company.
  • 28.11.
    ·
    28.11.
    ·
    Is DNB momentarily empty?
  • 27.11.
    ·
    27.11.
    ·
    Smart to subscribe to rep.emi at kr. 1,8 😎
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    What is rep.emi?
  • 12.11.
    ·
    12.11.
    ·
    Rep emi was probably 1.8kr? A bit odd that it falls below
    13.11.
    ·
    13.11.
    ·
    A bit peculiar that they are experiencing a nearly 20 % decline in sales, while at the same time opening sales offices, entering into agreements, winning awards for their products, and hiring more people. Yes, there's a lot that seems a bit peculiar with this company.
  • 23.10.
    ·
    23.10.
    ·
    The stock will probably go up when the new factory is up and running. https://www.opp.no/naeringsliv/mn24/n/1M0Jbe/sikrer-fabrikkutbygging-med-utenlandsk-partner
    24.10.
    ·
    24.10.
    ·
    MN24 Secures major expansion with foreign giant company German giant company contributes with a large loan to Hofseth Biocare which secures the expansion of the factory at Berkåk – and a tripling of exports from the Rennebu company. Hofseth Biocare has operated in Tine's old dairy premises at Berkåk, and is now planning a major expansion. PHOTO: JAN INGE FLÅ Per Roar Bekken Editor Updated: February 21, 2025 at 13:38 The expansion was announced in December. Managing Director of Hofseth Biocare ASA, Jon Olav Ødegård, then indicated to OPP an investment of between 100 and 200 million and a fivefold increase in staff from 8 to 40 employees. READ ALSO: Announces giant expansion: – Provides over 30 new jobs On Friday, the listed company issued a stock exchange announcement that they have entered into a partnership with the German giant corporation Symrise AG. The group enters and finances the expansion through a loan of 5 million euro (58 million kr). The facility at Berkåk is now fully financed with Symrise's loan and 60 million kroner in loans from Sparebank1 Nordmøre. "We expect all permits for the expansion of the facility to be approved by the second quarter of 2025, and the construction of the new hydrolysis plant will start immediately thereafter. Preliminary production start is set for the second quarter of 2027.", it states in the announcement.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
3 000
Myynti
Määrä
20 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
15--
9--
1 200--
1 320--
2 500--
Ylin
1,45
VWAP
-
Alin
1,29
VaihtoMäärä
0,1 99 853
VWAP
-
Ylin
1,45
Alin
1,29
VaihtoMäärä
0,1 99 853

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
13.2.2026
Menneet tapahtumat
2025 Q3 -tulosraportti7.11.
2025 Q2 -tulosraportti22.8.
2025 Q1 -tulosraportti16.5.
2024 Q4 -tulosraportti14.2.
2024 Q3 -tulosraportti8.11.2024
Datan lähde: FactSet, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti

Vain PDF

36 päivää sitten

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4 -tulosraportti
13.2.2026
Menneet tapahtumat
2025 Q3 -tulosraportti7.11.
2025 Q2 -tulosraportti22.8.
2025 Q1 -tulosraportti16.5.
2024 Q4 -tulosraportti14.2.
2024 Q3 -tulosraportti8.11.2024
Datan lähde: FactSet, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 8.12. · Muokattu
    ·
    8.12. · Muokattu
    ·
    When will the shares from the repair issue arrive in the ASK that were subscribed at a price of NOK 1.80?
    9.12.
    ·
    9.12.
    ·
    Interest in the repair issue was very low, which suggests that investors are starting to lose patience with the company, as promises of profit are constantly being postponed. This can have several consequences for both the company and the issue: 1. Low amount raised: If few shareholders subscribe, the company will not raise as much capital as planned. This could mean that the company does not get the funds it needs to finance projects, repay debt, or strengthen its balance sheet. 2. The issue may be postponed or canceled: Many issues have a «minimum threshold» for them to be carried out. If interest is low, the board may choose to postpone the issue, change the terms, or, in the worst case, cancel it. 3. Price pressure on the share: Low interest may indicate that the market does not value the company highly, which may mean that the issue price must be set lower to attract investors. This can lead to dilution for existing shareholders at a lower value than expected. 4. Signal to the market: Low interest can send a negative signal about the company's financial situation or future prospects. This can lead to a further fall in the share price, and make it more difficult to raise capital later. 5. The board may have to find alternative solutions: If the repair issue does not provide the desired capital, the company may have to consider other financing methods, such as loans, private placements, strategic partners, or cost cuts. In short: low interest in a repair issue is a bad sign for both the company's financial situation and shareholder values.
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    This can also be an attractive opportunity for those who tolerate high risk, especially considering that founder Roger Hofseth himself has invested over 50 million kroner in the issuance. The risk is still significant, but I consider the downside risk to be limited, at least until 2026, from my perspective. The securities fund DNB SMB has completed a sell-off of over 2 million shares and is now completely out of the company.
  • 28.11.
    ·
    28.11.
    ·
    Is DNB momentarily empty?
  • 27.11.
    ·
    27.11.
    ·
    Smart to subscribe to rep.emi at kr. 1,8 😎
    3 päivää sitten
    ·
    3 päivää sitten
    ·
    What is rep.emi?
  • 12.11.
    ·
    12.11.
    ·
    Rep emi was probably 1.8kr? A bit odd that it falls below
    13.11.
    ·
    13.11.
    ·
    A bit peculiar that they are experiencing a nearly 20 % decline in sales, while at the same time opening sales offices, entering into agreements, winning awards for their products, and hiring more people. Yes, there's a lot that seems a bit peculiar with this company.
  • 23.10.
    ·
    23.10.
    ·
    The stock will probably go up when the new factory is up and running. https://www.opp.no/naeringsliv/mn24/n/1M0Jbe/sikrer-fabrikkutbygging-med-utenlandsk-partner
    24.10.
    ·
    24.10.
    ·
    MN24 Secures major expansion with foreign giant company German giant company contributes with a large loan to Hofseth Biocare which secures the expansion of the factory at Berkåk – and a tripling of exports from the Rennebu company. Hofseth Biocare has operated in Tine's old dairy premises at Berkåk, and is now planning a major expansion. PHOTO: JAN INGE FLÅ Per Roar Bekken Editor Updated: February 21, 2025 at 13:38 The expansion was announced in December. Managing Director of Hofseth Biocare ASA, Jon Olav Ødegård, then indicated to OPP an investment of between 100 and 200 million and a fivefold increase in staff from 8 to 40 employees. READ ALSO: Announces giant expansion: – Provides over 30 new jobs On Friday, the listed company issued a stock exchange announcement that they have entered into a partnership with the German giant corporation Symrise AG. The group enters and finances the expansion through a loan of 5 million euro (58 million kr). The facility at Berkåk is now fully financed with Symrise's loan and 60 million kroner in loans from Sparebank1 Nordmøre. "We expect all permits for the expansion of the facility to be approved by the second quarter of 2025, and the construction of the new hydrolysis plant will start immediately thereafter. Preliminary production start is set for the second quarter of 2027.", it states in the announcement.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayOslo Børs
Määrä
Osto
3 000
Myynti
Määrä
20 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
15--
9--
1 200--
1 320--
2 500--
Ylin
1,45
VWAP
-
Alin
1,29
VaihtoMäärä
0,1 99 853
VWAP
-
Ylin
1,45
Alin
1,29
VaihtoMäärä
0,1 99 853

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt